CITIGROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$3,853
-93.3%
1,315
-93.4%
0.00%
Q2 2023$57,171
+1474.5%
19,990
+1601.3%
0.00%
Q1 2023$3,631
-49.0%
1,175
-65.2%
0.00%
Q4 2022$7,115
-28.8%
3,372
+7.5%
0.00%
Q3 2022$10,000
-23.1%
3,138
-25.1%
0.00%
Q2 2022$13,000
-84.5%
4,187
-64.7%
0.00%
Q1 2022$84,000
+189.7%
11,859
+191.7%
0.00%
Q4 2021$29,000
-38.3%
4,066
+0.1%
0.00%
Q3 2021$47,0004,0620.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders